Published in Medical Letter on the CDC and FDA, January 21st, 2001
The Antiretroviral Treatment and Access Study (ARTAS) is funded with a multi-site, four-year grant by the U.S. Centers for Disease Control and Prevention(CDC) and will look specifically at strategies to increase access to care for low-income, HIV infected persons. The study sites are Atlanta, Georgia; Baltimore, Maryland; Los Angeles, California; and Miami,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.